Silence Therapeutics plc
USD6.41
+0.04 (+0.63%)
CEO
Iain Gladstone Ross
IPO Date
2020-09-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
GB
Open
$6.36
Prev. Close
$6.37
Day Low
$6.34
Day High
$6.56
52W Low
$4.19
52W High
$8.40
Market Cap
$0.30B
Volume
0.12M
| 2,000 |
| $7.75 |
| 13 Feb 2026 | Griffiths Richard Ian | 10 percent owner | S-Sale | Acquired | 2,000 | $7.75 |
| 13 Feb 2026 | Griffiths Richard Ian | 10 percent owner | S-Sale | Acquired | 20,000 | $5.45 |
| 6 Jan 2026 | Ede-Golightly James | director | A-Award | Acquired | 90,000 | $2.05 |
| 6 Jan 2026 | MCINERNEY TIMOTHY | director | A-Award | Acquired | 90,000 | $2.05 |
| 6 Jan 2026 | Romano Steven J. | EVP and Chief R&D Officer | A-Award | Acquired | 300,000 | $2.05 |
| 6 Jan 2026 | HELLUMS RHONDA LYNETTE | director, officer: Chief Financial Officer | A-Award | Acquired | 375,000 | $2.05 |
| 6 Jan 2026 | Lemus David | director | A-Award | Acquired | 90,000 | $2.05 |
| 22 Dec 2025 | Ross Iain | director, officer: Interim PEO | A-Award | Acquired | 900,000 | $2.08 |